WebLegal Name Curis, Inc. Stock Symbol NASDAQ:CRIS Company Type For Profit Contact Email [email protected] Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. WebPipeline Overview - Curis, Inc Pipeline Overview We are focused on the development and commercialization of innovative therapeutics for the treatment of cancer. * IP licensed from Aurigene ** Exclusive option to license IP from ImmuNext *** IP licensed to Genentech (Curis receives royalty income)
Curis, Inc. (CRIS) Stock Forum & Discussion - Yahoo Finance
WebSep 26, 2024 · Curis Provides Third Quarter 2024 Business Update • PR Newswire (US) • 11/09/2024 09:01:00 PM ; Curis Announces Three Presentations at SITC 2024 • PR Newswire (US) • 11/07/2024 09:01:00 PM ; Curis to Release Third Quarter 2024 Financial Results and Hold Conference Call on November 9, 2024 • PR Newswire (US) • … WebCompany Overview - Curis, Inc Company Overview We are a biotechnology company focused on the development of first-in-class and innovative therapeutics for the treatment … fly shop bozeman montana
Curis, Inc. (CRIS) Stock Price, Quote & News - Stock Analysis
WebAt Curis, we are developing differentiated therapeutics with the goal of improving the lives of cancer patients. Our new animation shows how Emavusertib (CA-4948) is being developed to target hematologic … WebCuris Inc Message board - Online Community of active, educated investors researching and discussing Curis Inc Stocks. Home. Home Page. Recent Posts Top Active Boards Popular Posts. Biotech Tweets Market Tweets Energy Industry Tweets. Official IV Sponsor Page. My Content. WebCuris, Inc. (CRIS) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 0.6100 +0.0095 (+1.58%) At close: 04:00PM EDT 0.6294 +0.02 (+3.18%) After hours: 07:46PM EDT 1d 5d 1m 6m... green pea with envy